St. Jude Medical to Present at the 34th Annual J.P. Morgan Healthcare Conference

ST. PAUL, Minn.--()--St. Jude Medical, Inc. (NYSE:STJ) will present at the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 13 in San Francisco. Michael T. Rousseau, incoming president and chief executive officer, will make a presentation about the company at approximately 10 a.m. PST. The presentation will also be webcast live at investors.sjm.com.

About St. Jude Medical

St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases. The company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical has four major clinical focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit sjm.com or follow us on Twitter, @StJudeMedicalIR.

Contacts

St. Jude Medical, Inc.
J.C. Weigelt, 651-756-4347
Investor Relations
jweigelt@sjm.com

St. Jude Medical, Inc.